Versant Venture Capital VI, L.P.

Average Profitability
0.91%
Insider Buys Quantity
6
Insider Buys Sum
$65.9M
Insider Sells Quantity
58
Insider Sells Sum
$62.42M

Insider Activity of Versant Venture Capital VI, L.P.

According to the SEC Form 4 filings, Versant Venture Capital VI, L.P., being in a position of

  1. 10 percent owner at Black Diamond Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 221600 shares for $1.4M,
    over all time since 2020-02-03, has bought 1789472 shares for $34M, and sold 729611 share for $18.34M.

The largest purchase of all time was on 2020-02-03 and amounted to 1789472 shares of Black Diamond Therapeutics, Inc. for $34M.

The largest sale of all time was on 2019-12-30 and amounted to 677838 shares of Akero Therapeutics, Inc. for $16.53M.

Biography of Versant Venture Capital VI, L.P.

No biography is available at this moment.

2024-10-29SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
67,905
0.1081%
$9.16$621,801-2.56%
2024-10-28SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
89,990
0.2667%
$9.66$869,2400%
2024-09-20SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.13M
1.8595%
$6.53$7.4M-15.2%
2024-09-13SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
9,269
0.0153%
$6.16$57,100-7.57%
2024-09-12SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
16,047
0.0263%
$6.00$96,309-3.19%
2024-09-11SaleMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
541,897
0.833%
$6.00$3.25M+1.01%
2024-08-28SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
221,600
0.3894%
$6.32$1.4M-42.54%
2024-08-12SaleTempest Therapeutics, Inc.
TPST
10 percent owner
387,999
2.043%
$1.10$426,993+35.84%
2024-08-08SaleTempest Therapeutics, Inc.
TPST
10 percent owner
400,000
1.814%
$1.35$540,040-3.73%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
157,895
3.0944%
$19.00$3M-7.95%
2021-06-22PurchaseCentury Therapeutics, Inc.
IPSC
10 percent owner
100,000
0.6416%
$20.00$2M-41%
2020-11-30SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
10,393
0.0287%
$33.15$344,513-60.65%
2020-11-19SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
130,017
0.3608%
$33.01$4.29M-58.75%
2020-11-18SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
536
0.0015%
$33.09$17,738-58.11%
2020-11-17SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
4,194
0.0117%
$33.05$138,611-58.09%
2020-11-16SaleBlack Diamond Therapeutics, Inc.
BDTX
director
200
0.0006%
$33.01$6,603-44.27%
2020-11-13SaleBlack Diamond Therapeutics, Inc.
BDTX
director
4,500
0.0128%
$33.77$151,984-32.78%
2020-11-12SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
15,598
0.0431%
$34.15$532,642-34.91%
2020-11-11SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
12,617
0.0348%
$34.73$438,217-35.73%
2020-11-10SaleBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
39,996
0.1101%
$33.74$1.35M-33.18%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.